Guangyan Si

Guangyan Si


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
GYGang Yuan
Gang Yuan
ZLZhiyin Liu
Zhiyin Liu
WWWeiming Wang
Weiming Wang
MLMengnan Liu
Mengnan Liu
YXYanneng Xu
Yanneng Xu
GSGuangyan Si
Guangyan Si
Hepatocellular carcinoma (HCC) has the sixth-highest new incidence and fourth-highest mortality worldwide. Transarterial chemoembolization (TACE) is one of the primary treatment strategies for unresectable HCC. However, the therapeutic effect is still unsatisfactory due to the insufficient distribution of antineoplastic drugs in tumor tissues and the worsened post-embolization tumor microenvironment (TME, e.g., hypoxia and reduced pH). Recently, using nanomaterials as a drug delivery platform for TACE therapy of HCC has been a research hotspot. With the development of nanotechnology, multifunctional nanoplatforms have been developed to embolize the tumor vasculature, creating conditions for improving the distribution and bioavailability of drugs in tumor tissues. Currently, the researchers are focusing on functionalizing nanomaterials to achieve high drug loading efficacy, thorough vascular embolization, tumor targeting, controlled sustained release of drugs, and real-time imaging in the TACE process to facilitate precise embolization and enable therapeutic procedures follow-up imaging of tumor lesions. Herein, we summarized the recent advances and applications of functionalized nanomaterials based on TACE against HCC, believing that developing these functionalized nanoplatforms may be a promising approach for improving the TACE therapeutic effect of HCC.

29 June 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
ZJZhang Jiaming
Zhang Jiaming
JFJiaYi Fang
JiaYi Fang
XYXU YANNENG
XU YANNENG
GSGuangyan Si
Guangyan Si
The rapid advancement of artificial intelligence (AI) and robotics has led to significant progress in various medical fields including interventional radiology (IR). This review focuses on the research progress and applications of AI and robotics in IR, including deep learning (DL), machine learning (ML), and convolutional neural networks (CNNs) across specialties such as oncology, neurology, and cardiology, aiming to explore potential directions in future interventional treatments. To ensure the breadth and depth of this review, we implemented a systematic literature search strategy, selecting research published within the last five years. We conducted searches in databases such as PubMed and Google Scholar to find relevant literature. Special emphasis was placed on selecting large-scale studies to ensure the comprehensiveness and reliability of the results. This review summarizes the latest research directions and developments, ultimately analyzing their corresponding potential and limitations. It furnishes essential information and insights for researchers, clinicians, and policymakers, potentially propelling advancements and innovations within the domains of AI and IR. Finally, our findings indicate that although AI and robotics technologies are not yet widely applied in clinical settings, they are evolving across multiple aspects and are expected to significantly improve the processes and efficacy of interventional treatments.

25 December 2023 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
YWYong Wang
Yong Wang
ZLZong-Lin Liu
Zong-Lin Liu
HYHai Yang
Hai Yang
RLRun Li
Run Li
SLSi-Jing Liao
Si-Jing Liao
YZYing Zhang
Ying Zhang

10 October 2025 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
GYGang Yuan
Gang Yuan
WWWeiming Wang
Weiming Wang
XJXiaohui Jia
Xiaohui Jia
ZLZhiying Liu
Zhiying Liu
RCRan Cui
Ran Cui
GSGuangyan Si
Guangyan Si
Abdominal aortic aneurysm (AAA) is a life-threatening vascular condition marked by localized aortic dilation and structural weakening of the vessel wall, often leading to catastrophic complications such as rupture. As one of the leading causes of acute aortic-related mortality in the elderly, AAA rupture underscores the critical need for effective therapeutic strategies to prevent this fatal outcome. Current clinical management relies heavily on surgical or endovascular repair for larger aneurysms to reduce rupture risk; however, early diagnostic tools and pharmacological interventions remain limited. Advances in nanoscience present promising opportunities for targeted imaging and drug delivery in AAA treatment. Multifunctional nanoparticles (NPs) can be precisely engineered with ligands or biomembrane coatings to enable site-specific drug accumulation, minimizing systemic side effects. Beyond targeted delivery, NPs enhance drug solubility, prolong circulation half-life, improve bioavailability, and maximize therapeutic efficiency. Furthermore, carefully designed nanobiomaterials can maintain long-term stability within the vascular system without cellular internalization. This review highlights the applications of NPs in AAA imaging and therapy, summarizes recent progress in NPs-based diagnostics and treatments, and discusses their potential to transform clinical outcomes in AAA management.

7 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ZJZhang Jiaming
Zhang Jiaming
JFJiayi Fang
Jiayi Fang
YXYanneng Xu
Yanneng Xu
GSGuangyan Si
Guangyan Si
The rapid advancement of artificial intelligence (AI) and robotics has led to significant progress in various medical fields, including interventional radiology (IR). This review focuses on the research progress and applications of AI and robotics in IR, including deep learning (DL), machine learning (ML), and convolutional neural networks (CNNs) across specialties such as oncology, neurology, and cardiology. To ensure the breadth and depth of this review, we implemented a systematic literature search strategy, selecting research published within the last five years. We conducted searches in databases such as PubMed and Google Scholar to find relevant literature. Special emphasis was placed on selecting large-scale studies to ensure comprehensiveness and reliability of the results. We discuss the role of AI techniques used before, during, and after intervention treatments and the advantages of robotics in achieving precise operations and reducing intra-operative risks. Challenges faced in the implementation of these techniques are also addressed. Finally, we explore the future trends and potential applications of AI and robotics in interventional therapy, highlighting their potential to improve patient treatment outcomes and quality of life.

11 August 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
CXCongqing Xie
Congqing Xie
GLGaoyi Li
Gaoyi Li
WWWei Wei
Wei Wei
WWWeiming Wang
Weiming Wang
BYBin Yang
Bin Yang
GYGang Yuan
Gang Yuan
Anomalous systemic arterial supply to the left lower lobe (ASALLL) is a rare congenital vascular malformation. It predominantly occurs in young and middle-aged adults, often presenting with recurrent hemoptysis of unknown etiology. The condition has a high clinical misdiagnosis rate, and its optimal treatment remains controversial. Traditional management involves surgical or thoracoscopic lobectomy with ligation of the anomalous artery. In recent years, with advancements in endovascular techniques, transcatheter arterial embolization (TAE) has gained increasing preference among patients due to its minimally invasive and highly effective nature. Previous cases have primarily employed coils or vascular plugs to occlude the anomalous artery, with no reported use of detachable coil combined with medical tissue glue for embolization. Here, we present the case of an 18-year-old male with hemoptysis, diagnosed with ASALLL via CTA, who underwent successful embolization of the anomalous systemic artery using detachable coils combined with medical tissue glue. The procedure was uneventful, with excellent postoperative recovery. At the 1-year follow-up, the patient remained asymptomatic, with no complications such as pulmonary necrosis or infection. We also reviewed recent literature on the diagnosis and management of this condition, discussing key points in its diagnosis and differential diagnosis, and comparing the advantages and disadvantages of surgical intervention versus TAE. It aims to provide more robust evidence for the accurate diagnosis and optimal treatment selection of this rare vascular anomaly.